Fairvalue-Calculator Fairvalue-Calculator
EN DE

LENSAR, Inc (LNSR) Fair Value & Analysis

Healthcare · US · Market cap $69.5M

Price$5.66
Fair Value$16.90
Upside+198.6%
Quality95/100
Evidence: Low Range $12.67 – $21.12

Fair value as of: Jun 23, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

LENSAR, Inc (LNSR) currently trades at $5.66, while our model-based Fair Value estimate is $16.90 — implying the stock looks roughly 198.6% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -9% Stryker Corporation (S1YK34) -45% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -5% Edwards Lifesciences Corporation (EW) -52% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is LENSAR, Inc (LNSR) undervalued?
As of Jun 23, 2026, our model estimates a fair value of $16.90 versus a price of $5.66 — about +199% (undervalued). Model-based estimate, not financial advice.
What is the fair value of LNSR?
Our 21-model fair value for LENSAR, Inc is $16.90 (as of Jun 23, 2026), built from audited fundamentals. The current price is $5.66.
What is the quality score of LNSR?
LENSAR, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.